ArticleClinical drug investigation2015

Cost-effectiveness of apixaban vs. other new oral anticoagulants for the prevention of stroke: an analysis on patients with non-valvular atrial fibrillation in the Greek healthcare setting.

Kostas Athanasakis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.